Burth Jonathan 4
4 · Vita Coco Company, Inc. · Filed May 1, 2026
Research Summary
AI-generated summary of this filing
Vita Coco (COCO) COO Jonathan Burth Exercises Options and Sells Shares
What Happened
Jonathan Burth, Chief Operating Officer of Vita Coco Company, exercised stock options to acquire a total of 60,000 shares (three exercises of 20,000 shares each) at an exercise price shown as $10.18 per share (recorded as $203,560 per block; total cash outlay reported $610,680). He simultaneously sold 60,000 common shares in open‑market transactions over April 29–30, 2026 for total gross proceeds of $3,900,000 (sales at $65.00, $62.50 and $67.50 per share). The pattern — exercise followed by immediate sale — is consistent with a cashless exercise and disposition to realize gains. The sales were effected pursuant to a Rule 10b5‑1 trading plan.
Key Details
- Transaction dates and prices:
- 2026-04-29: Exercised 20,000 shares @ $10.18 (Acquired) = $203,560; Sold 20,000 shares @ $65.00 = $1,300,000
- 2026-04-29: Exercised 20,000 shares @ $10.18 (Acquired) = $203,560; Sold 20,000 shares @ $62.50 = $1,250,000
- 2026-04-30: Exercised 20,000 shares @ $10.18 (Acquired) = $203,560; Sold 20,000 shares @ $67.50 = $1,350,000
- The filing also shows three derivative "disposed" entries for 20,000 shares each at $0.00 (reported as derivative dispositions in the Form 4).
- Aggregate: Acquired (by exercise) = 60,000 shares (total reported cost $610,680); Sold = 60,000 shares (total proceeds $3,900,000). Approximate pre‑tax net proceeds ≈ $3.29M.
- Shares owned after transaction: Not provided in the excerpt of the filing.
- Notable footnotes: Sales were effected pursuant to a Rule 10b5‑1 trading plan (F1). The option(s) involved were reported as vested/exercisable per the filing (see related vesting/performance footnotes F2, F3, F6, etc.), indicating the exercises were permitted under the grant terms.
- Filing timeliness: No late filing flag indicated in the provided data.
Context
Exercising options and immediately selling the acquired shares is a common way for insiders to lock in gains and cover exercise costs and taxes; because the sales were done under a 10b5‑1 plan, they were pre‑scheduled trades rather than ad‑hoc market timing. For retail investors: purchases by insiders may be stronger signals than pre‑planned sales. These transactions are factual disclosures of insider activity and do not, by themselves, indicate management sentiment beyond the reported actions.
Insider Transaction Report
- Exercise/Conversion
Common Stock
2026-04-29$10.18/sh+20,000$203,560→ 77,910 total - Sale
Common Stock
[F1]2026-04-29$65.00/sh−20,000$1,300,000→ 77,910 total - Exercise/Conversion
Common Stock
2026-04-29$10.18/sh+20,000$203,560→ 97,910 total - Sale
Common Stock
[F1]2026-04-29$62.50/sh−20,000$1,250,000→ 57,910 total - Exercise/Conversion
Common Stock
2026-04-30$10.18/sh+20,000$203,560→ 77,910 total - Sale
Common Stock
[F1]2026-04-30$67.50/sh−20,000$1,350,000→ 57,910 total - Exercise/Conversion
Non-Qualified Stock Option (Right to Buy)
[F2]2026-04-29−20,000→ 113,575 totalExercise: $10.18Exp: 2030-02-10→ Common Stock (20,000 underlying) - Exercise/Conversion
Non-Qualified Stock Option (Right to Buy)
[F2]2026-04-29−20,000→ 93,575 totalExercise: $10.18Exp: 2030-02-10→ Common Stock (20,000 underlying) - Exercise/Conversion
Non-Qualified Stock Option (Right to Buy)
[F2]2026-04-30−20,000→ 73,575 totalExercise: $10.18Exp: 2030-02-10→ Common Stock (20,000 underlying)
- 40,950
Non-Qualified Stock Option (Right to Buy)
[F3]Exercise: $10.18Exp: 2030-02-10→ Common Stock (40,950 underlying) - 34,125
Non-Qualified Stock Option (Right to Buy)
[F2]Exercise: $10.18Exp: 2031-01-11→ Common Stock (34,125 underlying) - 58,043
Non-Qualified Stock Option (Right to Buy)
[F4]Exercise: $15.00Exp: 2031-10-21→ Common Stock (58,043 underlying) - 42,980
Non-Qualified Stock Option (Right to Buy)
[F5]Exercise: $15.36Exp: 2032-08-15→ Common Stock (42,980 underlying) - 14,025
Non-Qualified Stock Option (Right to Buy)
[F6]Exercise: $16.91Exp: 2033-03-10→ Common Stock (14,025 underlying) - 14,205
Non-Qualified Stock Option (Right to Buy)
[F7]Exercise: $16.91Exp: 2033-03-10→ Common Stock (14,205 underlying) - 8,746
Non-Qualified Stock Option (Right to Buy)
[F8]Exercise: $26.18Exp: 2034-03-04→ Common Stock (8,746 underlying) - 13,218
Non-Qualified Stock Option (Right to Buy)
[F9]Exercise: $33.36Exp: 2035-03-04→ Common Stock (13,218 underlying)
Footnotes (9)
- [F1]The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.
- [F2]The stock option is fully vested and currently exercisable.
- [F3]The stock option is eligible to vest in four tranches if certain performance conditions for each tranche of the option are met by the target date for the applicable performance condition(s) and expire relative to each tranche if the performance conditions for such tranche are not met by the final target date. The performance conditions were partially met and as a result, the first tranche of the option were timely satisfied, resulting in vesting of the option as to 18,200 shares on February 6, 2024. The performance conditions applicable to the fourth tranche of the option were timely satisfied, resulting in vesting of the option as to 22,750 shares on February 20, 2026.
- [F4]The stock option vests in four equal annual installments beginning on November 27, 2022.
- [F5]The stock option vests in three equal annual installments beginning on August 15, 2025.
- [F6]The stock option is eligible to vest if certain performance conditions are met by the target date for the applicable performance condition(s) and expire if the performance conditions are not met by the final target date. The performance conditions applicable were timely satisfied, resulting in vesting of the option as to 14,025 shares on February 20, 2026.
- [F7]The stock option vests in four equal annual installments beginning on March 10, 2024.
- [F8]The stock option vests in four equal annual installments beginning on March 4, 2025.
- [F9]The Reporting Person was granted stock options that will vest in four annual equal installments on each anniversary of the grant date provided that the Reporting Person remains in continuous service on each vesting date.